Form 8-K - Current report:
SEC Accession No. 0001437749-17-016481
Filing Date
2017-09-28
Accepted
2017-09-28 17:13:35
Documents
2
Period of Report
2017-09-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atrn20170928_8k.htm 8-K 24202
2 EXHIBIT 99.1 ex_96060.htm EX-99.1 12883
  Complete submission text file 0001437749-17-016481.txt   38468
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 171108306
SIC: 7389 Services-Business Services, NEC